MedPath

Hypothermia in Acute Spinal cord Injury

Phase 1
Not yet recruiting
Conditions
Fracture of third cervical vertebra,
Registration Number
CTRI/2020/02/023146
Lead Sponsor
Department of Orthopedics PGIMER
Brief Summary

In our study we hypothesize that modest hypothermia(33oC)for a duration of 24 hours in  patientswith acute traumatic spinal cord injuries is neuroprotective  and thus limits the neurological dysfunctioncaused by the trauma . Hypothermia suppresses the inflammatory processesand reduction in free radicals like super oxide, nitric oxide and hydroxylradicals are believed to be instrumental in preventing neuronal damage afterbrain and spinal cord injury.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria
  • 1.Patient of age group 18 – 65 years.
  • 2.Patients with closed spinal cord injury.
  • 3.Patients with GCS 15/15.
  • 4.AIS score A 5.Patient willing/giving consent to take part in the study.
Exclusion Criteria
  • 1.Age <18 or >65 years 2.AIS score B, C , D or E 3.Hyperthermia >38.5 0C on admission 4.Polytrauma patients 5.History of Severe bleeding, Coagulopathy, Thrombocytopenia 6.History of cardiac disease 7.Pancreatitis 8.History of Raynaud syndrome 9.Complete Spinal cord transection by MRI on Admission 10.Patients intubated/ sedated prior to neurological examination 11.Patients presenting to the hospital after 24 hours of injury.
  • 12.Patient not willing to participate in study/ not giving consent.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Neurological improvement by ASIA scoringDay1, Day7, Day14, Day42, Day84, Day168
Secondary Outcome Measures
NameTimeMethod
Pain SensitivityDay1, Day7, Day14, Day42, Day84, Day168

Trial Locations

Locations (1)

Advance Trauma Centre

🇮🇳

Chandigarh, CHANDIGARH, India

Advance Trauma Centre
🇮🇳Chandigarh, CHANDIGARH, India
Prashasth B S
Principal investigator
09480771647
bsp1493@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.